Another Wockhardts manufacturing plant caught under MHRAs vigilance

Wockhardt, a Mumbai based pharmaceutical major, had recently received a withdrawal of GMP certification for its plant in Chikalthana facility, Aurangabad in Maharashtra. While the company was struggling with this issue, another concern was raised over its manufacturing facility in Kadaiya, Nani Daman in Gujarat.
According to the companys statement, the quality compliance certificate or production permit, issued to this manufacturing plant has been cancelled by Medicines and Healthcare Products Regulatory Agency (MHRA), the UK health regulator. With this, the regulator has decided to withdraw the previously issued GMP (Good manufacturing practice) certificate to the companys manufacturing plant at Nani Daman. This is the companys third plant under GMP issues and the second plant to have GMP certificate withdrawn this year.

It is stated that MHRA may issue a restricted GMP certificate to the Nani Daman manufacturing unit, with a note of non-compliance. The company states that MHRA will continue with the restricted GMP certificate for continued manufacturing and quality control testing of critical products. This step would avoid shortage of drugs in the UK market and this plant would continue to manufacture and supply critical products for public health.